300194 福安药业
已收盘 07-31 15:00:00
资讯
新帖
简况
股市必读:福安药业(300194)7月30日董秘有最新回复
证券之星 · 07-31 01:55
股市必读:福安药业(300194)7月30日董秘有最新回复
福安药业:公司近两年来受药品集采政策影响,经营业绩承压
证券之星 · 07-30 16:27
福安药业:公司近两年来受药品集采政策影响,经营业绩承压
股市必读:福安药业(300194)股东户数3.79万户,较上期增加6.08%
证券之星 · 07-27
股市必读:福安药业(300194)股东户数3.79万户,较上期增加6.08%
福安药业(300194)披露子公司收到盐酸溴己新注射液药品注册证书,7月24日股价下跌3.23%
证券之星 · 07-24
福安药业(300194)披露子公司收到盐酸溴己新注射液药品注册证书,7月24日股价下跌3.23%
股市必读:福安药业(300194)7月23日董秘有最新回复
证券之星 · 07-24
股市必读:福安药业(300194)7月23日董秘有最新回复
福安药业:公司对未来发展保持信心
证券之星 · 07-23
福安药业:公司对未来发展保持信心
福安药业(300194.SZ):“注射用盐酸万古霉素”获得药品注册证书
智通财经 · 07-02
福安药业(300194.SZ):“注射用盐酸万古霉素”获得药品注册证书
股市必读:福安药业(300194)股东户数3.58万户,较上期增加0.07%
证券之星 · 06-24
股市必读:福安药业(300194)股东户数3.58万户,较上期增加0.07%
福安药业:截止6月18日,公司股东户数为35761户
证券之星 · 06-23
福安药业:截止6月18日,公司股东户数为35761户
福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用
证券之星 · 06-04
福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用
福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书
智通财经 · 06-03
福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书
股市必读:福安药业(300194)6月1日董秘有最新回复
证券之星 · 06-02
股市必读:福安药业(300194)6月1日董秘有最新回复
福安药业:截止5月29日,公司股东户数为36087户
证券之星 · 06-01
福安药业:截止5月29日,公司股东户数为36087户
福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书
证券之星 · 05-22
福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书
福安药业:截止5月20日,公司股东户数为36449户
证券之星 · 05-22
福安药业:截止5月20日,公司股东户数为36449户
福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%
证券之星 · 05-21
福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%
福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%
证券之星 · 05-20
福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%
福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降
证券之星 · 05-19
福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降
股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%
证券之星 · 05-13
股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%
福安药业:截止5月8日,公司股东户数为37090户
证券之星 · 05-12
福安药业:截止5月8日,公司股东户数为37090户
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":3.71,"timestamp":1785481389000,"preClose":3.68,"halted":0,"volume":15390400,"delay":0,"changeRate":0.0082,"floatShares":968000000,"shares":1190000000,"eps":0.0529,"marketStatus":"已收盘","change":0.03,"latestTime":"07-31 15:00:00","open":3.68,"high":3.71,"low":3.67,"amount":56869700,"amplitude":0.0109,"askPrice":3.71,"askSize":1579,"bidPrice":3.7,"bidSize":1475,"shortable":0,"etf":0,"ttmEps":0.0529,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785720600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.68,"symbolType":"stock","openAndCloseTimeList":[[1785461400000,1785468600000],[1785474000000,1785481200000]],"highLimit":4.05,"lowLimit":3.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":0.99,"roa":"--","peRate":70.132325,"roe":"1.25%","epsLYR":0.06,"committee":0.044561,"marketValue":4414000000,"turnoverRate":0.0159,"status":0,"floatMarketCap":3593000000},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2655072298","title":"股市必读:福安药业(300194)7月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655072298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655072298?lang=zh_cn&edition=full","pubTime":"2026-07-31 01:55","pubTimestamp":1785434115,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,福安药业报收于3.68元,下跌0.54%,换手率1.62%,成交量15.68万手,成交额5809.45万元。董秘最新回复投资者: 对比 2024 至 2025 年年报披露信息,公司在岗员工规模有所收缩,人均创收同步承压。公司准备采取何种方式改善人均经营效能,合理控制人员流失。当日关注点交易信息汇总:7月30日主力资金净流入373.94万元,占总成交额6.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0060","BK0132","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655821252","title":"福安药业:公司近两年来受药品集采政策影响,经营业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2655821252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655821252?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:27","pubTimestamp":1785400029,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业07月30日在投资者关系平台上答复投资者关心的问题。公司准备采取何种方式改善人均经营效能,合理控制人员流失。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000025627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300194","BK0132","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654906436","title":"股市必读:福安药业(300194)股东户数3.79万户,较上期增加6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654906436","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654906436?lang=zh_cn&edition=full","pubTime":"2026-07-27 01:46","pubTimestamp":1785087974,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,福安药业报收于3.59元,下跌3.23%,换手率1.51%,成交量14.59万手,成交额5322.33万元。股本股东变化:截至7月20日股东户数为3.79万户,较6月18日增长6.08%,户均持股由3.33万股降至3.14万股。股本股东变化股东户数变动截至2026年7月20日公司股东户数为3.79万户,较6月18日增加2176.0户,增幅为6.08%;户均持股数量由上期的3.33万股减少至3.14万股,户均持股市值为11.79万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300194","BK0060","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653351033","title":"福安药业(300194)披露子公司收到盐酸溴己新注射液药品注册证书,7月24日股价下跌3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653351033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653351033?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:34","pubTimestamp":1784903661,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,福安药业报收于3.59元,较前一交易日下跌3.23%,最新总市值为42.71亿元。该股当日开盘3.68元,最高3.72元,最低3.59元,成交额达5322.33万元,换手率为1.51%。福安药业(集团)股份有限公司当日发布公告称,其全资子公司福安药业集团宁波天衡制药有限公司收到国家药品监督管理局签发的盐酸溴己新注射液药品注册证书,批准文号为国药准字H20265301,注册分类为化药3类,规格为2ml:4mg。截至目前,共有30家企业通过或视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712727","title":"股市必读:福安药业(300194)7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712727","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653712727?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:08","pubTimestamp":1784830095,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘,福安药业报收于3.71元,上涨0.27%,换手率1.75%,成交量16.97万手,成交额6242.3万元。当日关注点交易信息汇总:7月23日主力资金净流出177.39万元,游资资金净流入482.67万元,散户资金净流出305.28万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0239","BK0060","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717323","title":"福安药业:公司对未来发展保持信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653717323?lang=zh_cn&edition=full","pubTime":"2026-07-23 15:51","pubTimestamp":1784793069,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问:8) 通常情况公司综合实力,行业地位会在资本市场的市值,PB等指标来体现 出来,目前公司市值、PB处于行业低位,请问公司如何定位自身行业位置?是否认为市场对公司存在定价错位?福安药业回复:您好,公司市值波动可能会受到行业周期、市场情绪、风格偏好等多方面因素的影响。尽管当前公司所在仿制药行业受政策影响较大,但公司对未来发展保持信心,将继续聚焦主业提质增效,在做好生产经营工作的同时,与投资者保持积极的交流互动。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300028285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","BK0060","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648577241","title":"福安药业(300194.SZ):“注射用盐酸万古霉素”获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2648577241","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648577241?lang=zh_cn&edition=full","pubTime":"2026-07-02 15:47","pubTimestamp":1782978433,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)发布公告,公司全资子公司福安药业集团湖北人民制药有限公司(以下简称“人民制药”)于近日收到国家药品监督管理局签发的药品注册证书,该药品为:“注射用盐酸万古霉素”。注射用盐酸万古霉素适用于耐甲氧西林金黄色葡萄球菌及其他细菌所致的感染:败血症,感染性心内膜炎、骨髓炎、关节炎、灼伤、手术创伤等浅表性继发感染、肺炎、肺脓肿、脓胸、腹膜炎、脑膜炎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ):“注射用盐酸万古霉素”获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300194","BK0060","BK0028","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645564668","title":"股市必读:福安药业(300194)股东户数3.58万户,较上期增加0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645564668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645564668?lang=zh_cn&edition=full","pubTime":"2026-06-24 03:34","pubTimestamp":1782243253,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,福安药业报收于3.6元,上涨2.86%,换手率1.88%,成交量18.24万手,成交额6583.84万元。当日关注点交易信息汇总:6月23日主力资金净流入387.89万元,占总成交额0.0%。股本股东变化股东户数变动截至2026年6月18日公司股东户数为3.58万户,较6月10日增加24.0户,增幅为0.07%。户均持股数量为3.33万股,户均持股市值为11.64万元。今天是6月中旬最后一个交易日,敬请发布最新的股东户数信息。董秘: 截止6月18日,公司股东户数为35761户,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400004161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885565","title":"福安药业:截止6月18日,公司股东户数为35761户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645885565?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:07","pubTimestamp":1782198435,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!今天是6月中旬最后一个交易日,敬请发布最新的股东户数信息。谢谢!顺致端午安康、节假快乐!福安药业回复:截止6月18日,公司股东户数为35761户,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300020204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640503061","title":"福安药业:公司目前没有在研发领域有AI技术布局、储备或落地应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2640503061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640503061?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:48","pubTimestamp":1780577302,"startTime":"0","endTime":"0","summary":"公司目前没有在研发领域有AI技术布局、储备或落地应用,也没有具体的运用AI技术进行研发升级与降本增效计划,公司将对相关技术前沿与应用动态保持关注,结合公司具体实际情况,选择符合自身需求的研发技术和战略,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300194","BK0132","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640221974","title":"福安药业(300194.SZ)子公司二氮嗪原料药获得FDA注册批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640221974","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640221974?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:56","pubTimestamp":1780473383,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)发布公告,公司全资子公司广安凯特制药有限公司(简称“广安凯特”)于近日收到美国食品药品监督管理局(简称“FDA”)签发的二氮嗪原料药注册批准通知书。二氮嗪(Diazoxide)是一种快速降压药及胰岛素分泌抑制剂,主要用于高血压危象和胰岛素瘤相关低血糖症的治疗。它通过激活血管平滑肌的钾离子通道,扩张血管降低血压,同时抑制胰腺β细胞释放胰岛素,调节血糖水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0132","BK4585","BK4588","LABU","BK0239","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640667399","title":"股市必读:福安药业(300194)6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640667399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640667399?lang=zh_cn&edition=full","pubTime":"2026-06-02 01:58","pubTimestamp":1780336693,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,福安药业报收于3.9元,上涨2.09%,换手率1.17%,成交量11.34万手,成交额4360.0万元。董秘最新回复投资者: 尊敬的董秘,您好!今天是5月份最后一个交易日,敬请发布截至5月底公司的股东户数信息。董秘: 截止5月29日,公司股东户数为36087户,谢谢!当日关注点来自交易信息汇总:6月1日主力资金净流入561.6万元,显示主力对个股短期关注度提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","BK0028","300194","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640346469","title":"福安药业:截止5月29日,公司股东户数为36087户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640346469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640346469?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:15","pubTimestamp":1780301756,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!今天是5月份最后一个交易日,敬请发布截至5月底公司的股东户数信息。谢谢!祝周末愉快!福安药业回复:截止5月29日,公司股东户数为36087户,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100022573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637392427","title":"福安药业最新公告:子公司收到米库氯铵注射液等药品注册证书及补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2637392427","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637392427?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:57","pubTimestamp":1779440254,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告称,公司全资子公司庆余堂近日收到国家药监局签发的药品注册证书及补充申请批准通知书。其中,米库氯铵注射液(化药4类,规格5ml:10mg、10ml:20mg)和聚多卡醇注射液(化药4类,规格2ml:10mg、2ml:20mg、2ml:60mg)获批注册;注射用头孢西丁钠(规格2.0g、1.0g、0.5g)的上市许可持有人由浙江惠迪森药业变更为庆余堂。上述药品的获批将进一步丰富子公司产品线,提升市场竞争力,但生产销售及业绩影响存在不确定性。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200030674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637362069","title":"福安药业:截止5月20日,公司股东户数为36449户","url":"https://stock-news.laohu8.com/highlight/detail?id=2637362069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637362069?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:36","pubTimestamp":1779420976,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至今天5月中旬末公司股东户数信息。谢谢!致礼!福安药业回复:截止5月20日,公司股东户数为36449户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637438212","title":"福安药业(300194)披露2025年年度权益分派实施公告,5月21日股价下跌1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637438212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637438212?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:26","pubTimestamp":1779359177,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,福安药业报收于3.89元,较前一交易日下跌1.52%,最新总市值为46.28亿元。该股当日开盘3.96元,最高3.99元,最低3.89元,成交额达3300.34万元,换手率为0.86%。近日,福安药业(集团)股份有限公司发布《2025年年度权益分派实施公告》。公告显示,公司2025年年度权益分派方案已获2026年5月19日召开的年度股东会审议通过。股权登记日为2026年5月27日,除权除息日为2026年5月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300194","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636843823","title":"福安药业(300194)披露2025年年度股东会决议公告,5月20日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636843823","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636843823?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:55","pubTimestamp":1779270915,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,福安药业报收于3.95元,较前一交易日下跌1.5%,最新总市值为46.99亿元。该股当日开盘4.0元,最高4.0元,最低3.93元,成交额达2331.08万元,换手率为0.61%。福安药业于近日披露《2025年年度股东会决议公告》。所有议案均获通过,中小投资者表决单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636588183","title":"福安药业:目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2636588183","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636588183?lang=zh_cn&edition=full","pubTime":"2026-05-19 11:34","pubTimestamp":1779161663,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业05月19日在投资者关系平台上答复投资者关心的问题。目前公司所处的行业受政策影响,市场竞争激烈,利润空间承压,整体业绩下降。公司将继续积极适应政策变化,采取有效措施降本增效,努力保持生产经营稳定,改善经营业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900019497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635249996","title":"股市必读:福安药业(300194)股东户数3.71万户,较上期减少0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635249996?lang=zh_cn&edition=full","pubTime":"2026-05-13 00:59","pubTimestamp":1778605150,"startTime":"0","endTime":"0","summary":"截至2026年5月12日收盘,福安药业报收于4.1元,下跌1.91%,换手率1.44%,成交量13.94万手,成交额5754.37万元。来自股本股东变化:截至5月8日股东户数环比下降0.23%,户均持股上升至3.21万股,筹码略有集中。股本股东变化股东户数变动截至2026年5月8日,福安药业股东户数为3.71万户,较4月30日减少87.0户,减幅0.23%。户均持股数量升至3.21万股,户均持股市值为13.25万元。董秘: 截止5月8日,公司股东户数为37090户,谢谢!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300001478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","BK0060","300194","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634426820","title":"福安药业:截止5月8日,公司股东户数为37090户","url":"https://stock-news.laohu8.com/highlight/detail?id=2634426820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634426820?lang=zh_cn&edition=full","pubTime":"2026-05-12 11:36","pubTimestamp":1778556997,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至5月上旬末公司股东户数信息。谢谢!致礼!福安药业回复:截止5月8日,公司股东户数为37090户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200016903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0132","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785567716898,"stockEarnings":[{"period":"1week","weight":0.0334},{"period":"1month","weight":0.054},{"period":"3month","weight":-0.0898},{"period":"6month","weight":-0.1629},{"period":"1year","weight":-0.1931},{"period":"ytd","weight":-0.1514}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":-0.0681},{"period":"3month","weight":-0.0681},{"period":"6month","weight":-0.0694},{"period":"1year","weight":0.0725},{"period":"ytd","weight":-0.0344}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"37937人(较上一季度增加6.08%)","perCapita":"25525股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}